| Ticker: | PSNL |
| Current Price: | $15.71 |
| % Daily Change: | -0.95% |
| Volume (1,000s): | 2,803.80 |
| Average Volume (1,000s): | 3,885.13 |
| Market Cap (M): | $1,703.02 |
| 1/2/2024 Price: | $2.04 |
| Change Since Inception: | 670.10% |
1330 OâBrien Drive
Menlo Park, CA 94025
United States
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.